Dr. Weibel studies the biochemistry, physiology, and behavior of microorganisms and has a long-term interest in developing strategies and technologies for diagnosing and treating infectious agents. Prior to beginning a faculty position at UW-Madison in 2006, he was a postdoctoral fellow in chemistry and engineering with G. M. Whitesides at Harvard University. Dr. Weibel has consulted for several governmental organizations (including the FDA) and has been a visiting scientist at Google[x], Orchid Cellmark (acquired by LabCorp), and the Max Planck Institute for Chemical Ecology. Following his BS in chemistry from the University of Utah, Dr. Weibel spent 1996 – 1997 as a Fulbright Fellow in Japan (Tohoku University). He received a PhD in chemistry from Cornell in 2002.